Latest ROE for ObsEva SA.: -3.52% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-352.22%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
ObsEva SA. (OBSV) currently reports a ROE of -3.52%. That is below the Healthcare sector average of 29.39%. Use the charts on this page to explore ObsEva SA.'s ROE history and peer comparisons.
ObsEva SA.'s ROE of -3.52% is lower than the Healthcare sector average of 29.39%. That is roughly 1298.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but ObsEva SA.'s current -3.52% should be judged against Healthcare norms (sector average: 29.39%) and against OBSV's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -3.52%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.39%. From there, open related valuation or income-statement pages for ObsEva SA., and consider following OBSV for alerts when major investors trade the stock.
ObsEva SA. is classified in the Healthcare sector. On ROE, it currently shows -3.52% versus a sector average near 29.39%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OBSV with unrelated industries.